Reishi: Dangers, Side Effects and Contraindications

At usual doses, reported adverse effects are rare and generally mild. The main issue is not inherent toxicity but a set of drug interactions, the most documented concerning anticoagulants and antiplatelet agents. In other words, reishi is rarely problematic in itself and can become so depending on what else you are taking.

Reported effects are essentially mild: dry mouth, throat or nose, itching, digestive disturbances such as bloating, mild nausea or diarrhea. Nosebleeds have also been described. These effects occur mainly at the start of use or at high doses, and generally subside upon discontinuation or after dose reduction.

No. The risk linked to oxalates and documented by cases of nephropathy is specific to chaga among common species. Reishi has a different safety profile, focused on drug interactions and bleeding risk. This is a good illustration of the fact that one should not reason about functional mushrooms as a group.

That reishi is generally well tolerated at usual doses, with mild and reversible effects, and that its safety concern lies elsewhere: in interactions. Anticoagulants and scheduled surgery constitute the central precaution, followed by antihypertensives, antidiabetics and immunosuppressants. The question to ask is not "am I in good health," but "what else am I already taking."

This is the central precaution for this species. Reishi is not recommended for people taking anticoagulants or antiplatelet agents, due to a potential effect on platelet aggregation that could increase bleeding risk. Nosebleeds are among the reported adverse effects. Do not take reishi without your doctor's advice in this situation.

Yes. Reishi is not recommended for people undergoing surgical intervention, for the same reason: the risk of perioperative bleeding. Stop taking it several days before and mention it at your preoperative consultation. This rule applies more broadly to many supplements.

Unusual bleeding, particularly from the nose or gums, bruises that appear easily, breathing difficulty, hives, or digestive disturbances that persist despite dose reduction. Stop taking it and consult while reporting the product, its dose and duration. An adverse effect can be reported under nutrivigilance.

Several categories require caution. Anticoagulants and antiplatelet agents first and foremost. Antihypertensives, as reishi may enhance a drop in blood pressure. Antidiabetics, with possible potentiation of blood sugar lowering. Immunosuppressants, as mushrooms act on immune pathways. And medications metabolized by certain liver enzymes.

An effect on blood pressure is suggested, which mainly raises questions in people already on antihypertensive treatment, in whom effects could add up. This is not a demonstrated effect in the sense of an authorized health claim, but a possible interaction to report to your doctor.

Caution is warranted. Mushrooms contain polysaccharides that act on immune pathways, which can theoretically interfere with immunosuppressive treatment or interact with an autoimmune disease. Medical advice is necessary before any use in these situations, including after organ transplantation.

Not without the agreement of your healthcare team. Interactions with certain protocols are possible, and the question of the effect on immune pathways is particularly relevant in this context. Always report any supplement to your oncologist: this information is part of your medical record just like any medication.

Combinations are common, but they accumulate precautions rather than dilute them. If you combine reishi and chaga for example, you accumulate the first one's anticoagulant precaution and the second one's oxalate concerns. The higher the stack, the less you know what produces what.

No, not without medical advice. Safety data is lacking in pregnant and breastfeeding women, which is sufficient to justify abstention. The same applies to children and adolescents, for whom no data supports routine use.

It is rare but possible, and the risk is higher in people already allergic to other mushrooms. A reaction may manifest as itching, hives, digestive problems, or, more rarely, respiratory discomfort. If you are allergic to mushrooms, do not take reishi. In case of respiratory discomfort after taking it, seek emergency care.

Safety data on very prolonged use is limited, which calls for caution. The reasonable approach is to favor defined periods rather than indefinite continuous intake, and to regularly reassess whether it is worthwhile to continue.

The determining question for safety remains the actual quantity ingested and the duration. That said, a dosed preparation with a clearly indicated quantity per dose provides more controlled intake than a powder consumed without reference. The distinction between fruiting body and mycelium on substrate, as well as beta-glucan content, relate to a different topic than safety.

Stop taking it and consult your doctor, reporting the product consumed, its dose, and duration. In case of unusual bleeding or respiratory discomfort, do not wait. An adverse effect potentially linked to a dietary supplement can also be reported as part of the national nutrivigilance system.

Yes, reishi is marketed as a dietary supplement in France. What is regulated is the claims: health claims concerning plants and mushrooms are pending evaluation at the European level, which means that no health claims can be made with certainty, including those about immunity, stress, or sleep.

Not on a label or in marketing communications. No such claims are authorized, and European authorities have ruled against the claim of stimulating immune defenses for other mushrooms in the same category, due to lack of convincing evidence. A brand displaying this goes outside the regulatory framework.